Burnos sveikatos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 38,192 | 47,609 | 556,130 | 65,789 | 66,715 | 62,518 | 47,195 | 23,401 |
| Profit before tax | 6,175 | 12,859 | 103,030 | 114 | -15,716 | -8,347 | -1,101 | -10,079 |
| Net profit | 5,821 | 12,211 | 87,539 | 40 | -15,716 | -8,347 | -1,101 | -10,079 |
| Equity | 21,506 | 33,717 | 103,609 | 101,849 | 86,233 | 77,886 | 76,785 | 66,706 |
| Liabilities | 21,078 | - | - | - | 21,018 | 13,909 | 15,892 | 4,800 |
| Non-current assets | 69 | 18,000 | 45,471 | 37,595 | 29,784 | 21,473 | 46,847 | 35,470 |
| Current assets | 42,515 | 42,801 | 106,414 | 137,341 | 77,467 | 70,322 | 45,830 | 36,036 |
| Total assets | 42,584 | 60,801 | 151,885 | 174,936 | 107,251 | 91,795 | 92,677 | 71,506 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,372 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +19.5% | +24.7% | +1068.1% | -88.2% | +1.4% | -6.3% | -24.5% | -50.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.7% | 20.1% | 57.6% | 0.0% | -14.7% | -9.1% | -1.2% | -14.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 27.1% | 36.2% | 84.5% | 0.0% | -18.2% | -10.7% | -1.4% | -15.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 15.2% | 25.6% | 15.7% | 0.1% | -23.6% | -13.4% | -2.3% | -43.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 16.2% | 27.0% | 18.5% | 0.2% | -23.6% | -13.4% | -2.3% | -43.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | - | - | - | 0.2 | 0.2 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 35,255 | 47,609 | 556,130 | 65,789 | 66,715 | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Burnos sveikatos centras - Social security debts
The company had no debts to Sodra
Burnos sveikatos centras - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Burnos sveikatos centras, MB (code 303128887) is a small partnership operating in retail sale of cosmetic and toilet articles. In 2025, the company generated revenue of €23.4K, down 50.4% year on year and 62.6% compared with 2023. Net loss widened to €10.1K in 2025, after a loss of €1.1K in 2024 and €8.3K in 2023. The 2025 profit margin was -43.1%, indicating that declining turnover was accompanied by weaker profitability.
The balance sheet remained relatively conservative. At the end of 2025, total assets amounted to €71.5K, equity to €66.7K and liabilities to €4.8K. The equity ratio was 93.3% and debt-to-equity stood at 0.07, showing limited leverage. Asset turnover was 0.33x, reflecting modest use of the asset base to generate sales. Over the last three years, the company moved from €91.8K in assets and €77.9K in equity in 2023 to a smaller balance sheet in 2025, while losses increased again after the narrower loss recorded in 2024.
The balance sheet remained relatively conservative. At the end of 2025, total assets amounted to €71.5K, equity to €66.7K and liabilities to €4.8K. The equity ratio was 93.3% and debt-to-equity stood at 0.07, showing limited leverage. Asset turnover was 0.33x, reflecting modest use of the asset base to generate sales. Over the last three years, the company moved from €91.8K in assets and €77.9K in equity in 2023 to a smaller balance sheet in 2025, while losses increased again after the narrower loss recorded in 2024.